BPC-157 20mg 20mg BPC-157 (Body Protection Compound-157) is one of the most widely studied peptides in regenerative medicine research
Researchers observed improvements in trabecular number, thickness, and connectivity density compared to vehicle-treated controls [2]
: 1 - 5 : , , - , , DSIP, DSIP 4H2O, WAGGDASGE, EMIDELTIDE, EMideltide, DSIP nonapeptide, SLEEP INDUCING PEPTIDE, DELTA SLEEP INDUCING PEPTIDE, DELTA SLEEP-INDUCING PEPTIDE 4H2O, DSIP/Delta Sleep Inducing Peptide
Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes
doi: 10.1093/jn/135.8.1847 112
383, 20 Nov